These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22419890)

  • 1. The silencing of RECK gene is associated with promoter hypermethylation and poor survival in hepatocellular carcinoma.
    Zhang C; Ling Y; Zhang C; Xu Y; Gao L; Li R; Zhu J; Fan L; Wei L
    Int J Biol Sci; 2012; 8(4):451-8. PubMed ID: 22419890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The silence of MUC2 mRNA induced by promoter hypermethylation associated with HBV in Hepatocellular Carcinoma.
    Ling Y; Zhu J; Gao L; Liu Y; Zhu C; Li R; Wei L; Zhang C
    BMC Med Genet; 2013 Jan; 14():14. PubMed ID: 23347460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation degree of metalloproteinase inhibitor RECK gene: Links to RECK protein level and hepatocellular carcinoma in chronic HCV infection patients.
    Abo El-Khair SM; Elalfy H; Diasty M; Ebrahim EE; Elsamanoudy AZ
    J Biochem Mol Toxicol; 2021 Oct; 35(10):e22886. PubMed ID: 34392581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased PADI4 mRNA association with global hypomethylation in hepatocellular carcinoma during HBV exposure.
    Zhang C; Fan L; Fan T; Wu D; Gao L; Ling Y; Zhu J; Li R; Wei L
    Cell Biochem Biophys; 2013 Mar; 65(2):187-95. PubMed ID: 22907585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
    Li Z; Zhang H; Yang J; Hao T; Li S
    Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypermethylation leads to bone morphogenetic protein 6 downregulation in hepatocellular carcinoma.
    He Y; Cui Y; Xu B; Gu J; Wang W; Luo X
    PLoS One; 2014; 9(1):e87994. PubMed ID: 24498236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of DENND2D by promoter hypermethylation is associated with early recurrence of hepatocellular carcinoma.
    Kanda M; Nomoto S; Oya H; Takami H; Hibino S; Hishida M; Suenaga M; Yamada S; Inokawa Y; Nishikawa Y; Asai M; Fujii T; Sugimoto H; Kodera Y
    Int J Oncol; 2014 Jan; 44(1):44-52. PubMed ID: 24189587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte growth factor activator inhibitor 2/placental bikunin (HAI-2/PB) gene is frequently hypermethylated in human hepatocellular carcinoma.
    Fukai K; Yokosuka O; Chiba T; Hirasawa Y; Tada M; Imazeki F; Kataoka H; Saisho H
    Cancer Res; 2003 Dec; 63(24):8674-9. PubMed ID: 14695180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic silencing of WIF-1 in hepatocellular carcinomas.
    Deng Y; Yu B; Cheng Q; Jin J; You H; Ke R; Tang N; Shen Q; Shu H; Yao G; Zhang Z; Qin W
    J Cancer Res Clin Oncol; 2010 Aug; 136(8):1161-7. PubMed ID: 20119713
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Anwar SL; Krech T; Hasemeier B; Schipper E; Schweitzer N; Vogel A; Kreipe H; Buurman R; Skawran B; Lehmann U
    World J Gastroenterol; 2017 Mar; 23(9):1568-1575. PubMed ID: 28321157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic inactivation of the canonical Wnt antagonist secreted frizzled-related protein 1 in hepatocellular carcinoma cells.
    Wu Y; Li J; Sun CY; Zhou Y; Zhao YF; Zhang SJ
    Neoplasma; 2012; 59(3):326-32. PubMed ID: 22296502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma.
    Kuo CC; Shih YL; Su HY; Yan MD; Hsieh CB; Liu CY; Huang WT; Yu MH; Lin YW
    World J Gastroenterol; 2015 Apr; 21(13):3960-9. PubMed ID: 25852282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells.
    Zhang C; Li H; Zhou G; Zhang Q; Zhang T; Li J; Zhang J; Hou J; Liew CT; Yin D
    J Pathol; 2007 Jun; 212(2):134-42. PubMed ID: 17471463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated expression of the stem cell marker CD133 associated with Line-1 demethylation in hepatocellular carcinoma.
    Zhang C; Xu Y; Zhao J; Fan L; Jiang G; Li R; Ling Y; Wu M; Wei L
    Ann Surg Oncol; 2011 Aug; 18(8):2373-80. PubMed ID: 21331808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypermethylation of NAD(P)H: quinone oxidoreductase 1 (NQO1) gene in human hepatocellular carcinoma.
    Tada M; Yokosuka O; Fukai K; Chiba T; Imazeki F; Tokuhisa T; Saisho H
    J Hepatol; 2005 Apr; 42(4):511-9. PubMed ID: 15763338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma.
    Shih YL; Shyu RY; Hsieh CB; Lai HC; Liu KY; Chu TY; Lin YW
    Cancer; 2006 Aug; 107(3):579-90. PubMed ID: 16795071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenomic profiling of DNA methylation for hepatocellular carcinoma diagnosis and prognosis prediction.
    Zhang C; Ge S; Wang J; Jing X; Li H; Mei S; Zhang J; Liang K; Xu H; Zhang X; Zhang C
    J Gastroenterol Hepatol; 2019 Oct; 34(10):1869-1877. PubMed ID: 31038805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of aberrant cyclin-dependent kinase-like 2 methylation in hepatocellular carcinoma.
    Zhou Y; Qiu XP; Li ZH; Zhang S; Rong Y; Yang GH; Fang-Zheng
    Gene; 2019 Jan; 683():35-40. PubMed ID: 30292871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant TIG1 methylation associated with its decreased expression and clinicopathological significance in hepatocellular carcinoma.
    Chen XH; Wu WG; Ding J
    Tumour Biol; 2014 Feb; 35(2):967-71. PubMed ID: 24006221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma.
    Lu B; Ma Y; Wu G; Tong X; Guo H; Liang A; Cong W; Liu C; Wang H; Wu M; Zhao J; Guo Y
    Clin Cancer Res; 2008 Nov; 14(22):7405-12. PubMed ID: 19010857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.